Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
64.02
-0.66 (-1.02%)
May 12, 2026, 3:00 PM CST

SHA:688513 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,16210,7315,2527,6597,3065,572
Market Cap Growth
94.94%104.34%-31.43%4.83%31.12%-2.50%
Enterprise Value
9,7209,2984,0106,4196,1123,987
Last Close Price
64.0261.5529.8442.4840.1130.07
PE Ratio
40.5037.7822.0533.8129.6423.97
Forward PE
36.7936.0716.2125.3322.56-
PS Ratio
8.268.063.896.866.245.45
PB Ratio
3.623.531.952.942.992.43
P/TBV Ratio
4.043.971.972.983.032.47
P/FCF Ratio
50.6360.0736.0276.60--
P/OCF Ratio
35.8340.5119.9527.8348.0937.75
EV/Sales Ratio
7.196.982.975.755.223.90
EV/EBITDA Ratio
35.2726.9416.0528.4728.3323.72
EV/EBIT Ratio
53.2436.8223.8142.1738.8329.43
EV/FCF Ratio
44.0952.0527.5064.19--
Debt / Equity Ratio
0.030.050.040.090.040.01
Debt / EBITDA Ratio
0.250.420.460.990.490.12
Debt / FCF Ratio
0.370.820.782.24--
Net Debt / Equity Ratio
-0.50-0.48-0.48-0.50-0.51-0.65
Net Debt / EBITDA Ratio
-4.64-4.25-5.24-5.76-5.76-8.83
Net Debt / FCF Ratio
-6.99-8.21-8.98-13.006.6312.11
Asset Turnover
0.370.370.400.350.400.39
Inventory Turnover
1.481.571.971.501.631.56
Quick Ratio
3.323.032.872.572.893.77
Current Ratio
3.823.453.232.853.234.11
Return on Equity (ROE)
8.76%9.54%8.99%8.98%10.41%10.60%
Return on Assets (ROA)
4.08%4.39%3.12%2.99%3.40%3.19%
Return on Invested Capital (ROIC)
13.64%15.58%11.80%11.39%14.74%19.36%
Return on Capital Employed (ROCE)
7.30%7.90%6.00%5.70%6.30%5.80%
Earnings Yield
2.46%2.65%4.54%2.96%3.37%4.17%
FCF Yield
1.98%1.67%2.78%1.31%-2.56%-2.20%
Dividend Yield
0.76%-1.44%0.93%0.95%1.76%
Payout Ratio
27.90%27.03%31.11%31.37%38.96%15.66%
Buyback Yield / Dilution
1.46%0.52%1.04%-0.14%-0.37%-19.70%
Total Shareholder Return
2.22%0.52%2.48%0.79%0.58%-17.94%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.